Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Kent W. Stanger sold 7,400 shares of Merit Medical Systems stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $42.22, for a total transaction of $312,428.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Merit Medical Systems, Inc. (NASDAQ MMSI) traded down 0.24% during midday trading on Wednesday, hitting $41.85. 257,003 shares of the stock traded hands. The company’s 50-day moving average is $38.37 and its 200 day moving average is $32.44. The firm has a market cap of $2.09 billion, a P/E ratio of 59.62 and a beta of 1.26. Merit Medical Systems, Inc. has a 12-month low of $20.70 and a 12-month high of $42.25.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The firm had revenue of $186.50 million during the quarter, compared to the consensus estimate of $181.46 million. During the same quarter in the previous year, the company posted $0.26 EPS. The firm’s revenue for the quarter was up 23.4% on a year-over-year basis. On average, analysts anticipate that Merit Medical Systems, Inc. will post $1.26 EPS for the current fiscal year.

WARNING: This report was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/08/09/merit-medical-systems-inc-mmsi-director-kent-w-stanger-sells-7400-shares.html.

Several equities research analysts have recently commented on the stock. Piper Jaffray Companies restated a “buy” rating and issued a $45.00 price target on shares of Merit Medical Systems in a report on Friday, July 28th. Craig Hallum restated a “buy” rating and issued a $50.00 price target (up previously from $42.00) on shares of Merit Medical Systems in a report on Thursday, July 27th. Bank of America Corporation assumed coverage on shares of Merit Medical Systems in a report on Thursday, July 20th. They issued a “buy” rating and a $44.00 price target for the company. Zacks Investment Research lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Wednesday, April 26th. Finally, Canaccord Genuity restated a “buy” rating and issued a $37.00 price target on shares of Merit Medical Systems in a report on Friday, April 28th. One equities research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $39.74.

A number of hedge funds have recently bought and sold shares of MMSI. Ameritas Investment Partners Inc. acquired a new stake in Merit Medical Systems during the first quarter valued at approximately $102,000. SG Americas Securities LLC acquired a new stake in Merit Medical Systems during the first quarter valued at approximately $134,000. LS Investment Advisors LLC boosted its stake in Merit Medical Systems by 8.1% in the second quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock valued at $141,000 after buying an additional 277 shares during the period. Advisors Asset Management Inc. boosted its stake in Merit Medical Systems by 28.2% in the second quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock valued at $142,000 after buying an additional 820 shares during the period. Finally, State of Alaska Department of Revenue boosted its stake in Merit Medical Systems by 13.1% in the first quarter. State of Alaska Department of Revenue now owns 5,430 shares of the medical instruments supplier’s stock valued at $156,000 after buying an additional 630 shares during the period. Institutional investors own 92.11% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.